Clin2
NCT07517211Likely a fitNot yet recruiting

Physical Function During Cancer Treatment for Stomach/Esophagus Cancer

Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage II Gastric Cancer AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

Part of Cancer, Digestive system clinical trials.

This study tracks how physical abilities (like strength, walking, and daily activities) change in adults receiving chemotherapy or other drug treatments for early-stage stomach or esophageal cancer. Understanding these changes may help doctors better support patients during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
72 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have a new diagnosis of stage I, II, or III stomach, esophageal junction, or esophageal cancer
  • You are planning to start systemic therapy (chemotherapy or targeted drugs) for your cancer
  • You can understand and sign an informed consent document
  • You do not have cancer that has spread to other parts of your body
  • You are not currently enrolled in another study focused on physical function, frailty, or muscle strength

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07439484Not yet recruiting
Remote exercise study for stomach or esophagus cancer survivors

This study tests a personalized, supervised exercise program that you can do from home. It aims to help improve your physical function after finishing treatment for early-stage gastroesophageal cancer.

Los Angeles, California
NCT06078709Recruiting· Phase 2
Pre-surgery radiation and chemo for esophageal cancer

This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.

Scottsdale, Arizona
NCT07290985Recruiting· Phase 2
Can biomarkers guide organ-sparing treatment for stomach and esophagus cancer?

This trial tests if using specific biomarkers (like HER2 and PD-L1) can help choose the best treatment to potentially avoid surgery. It aims to preserve the stomach or esophagus while effectively treating the cancer.

Los Angeles, California
NCT06138223Recruiting
Exercise and diet for incurable esophagus or stomach cancer

This study tests whether an exercise and nutrition program can improve quality of life for people with incurable esophageal or stomach cancer. It is designed to help you feel better and stay active during treatment.

Amsterdam, North Holland
NCT06430346Recruiting
Exercise before treatment for esophageal cancer

This trial tests whether a personalized exercise program before standard treatment (chemoradiation and surgery) can help people with esophageal cancer feel stronger and recover better. If you are scheduled for this treatment and are not already doing regular strength training, you may be able to join.

Tampa, Florida
NCT06923020Enrolling by invitation
Nutrition and immunotherapy for advanced stomach and esophagus cancer

This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.

Zhengzhou, Henan

Hear when a new Clinical Stage I Esophageal Adenocarcinoma AJCC v8 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.